200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 10470-83-4

10470-83-4

10470-83-4 | 5,8-QUINOLINEQUINONE

CAS No: 10470-83-4 Catalog No: AG008TXL MDL No:MFCD04038780

Product Description

Catalog Number:
AG008TXL
Chemical Name:
5,8-QUINOLINEQUINONE
CAS Number:
10470-83-4
Molecular Formula:
C9H5NO2
Molecular Weight:
159.1415
MDL Number:
MFCD04038780
IUPAC Name:
quinoline-5,8-dione
InChI:
InChI=1S/C9H5NO2/c11-7-3-4-8(12)9-6(7)2-1-5-10-9/h1-5H
InChI Key:
NVJSPQCVDHGYRE-UHFFFAOYSA-N
SMILES:
O=C1C=CC(=O)c2c1nccc2
NSC Number:
682996

Properties

Complexity:
257  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
159.032g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
159.144g/mol
Monoisotopic Mass:
159.032g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
47A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.7  

Literature

Title Journal
New quinoline-5,8-dione and hydroxynaphthoquinone derivatives inhibit a chloroquine resistant Plasmodium falciparum strain. European journal of medicinal chemistry 20120801
Application of porous nickel-coated TiO₂ for the photocatalytic degradation of aqueous quinoline in an internal airlift loop reactor. International journal of environmental research and public health 20120201
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway. Cancer chemotherapy and pharmacology 20081001
The aza-analogues of 1,4-naphthoquinones are potent substrates and inhibitors of plasmodial thioredoxin and glutathione reductases and of human erythrocyte glutathione reductase. Organic & biomolecular chemistry 20080807
Discovery of quinolinediones exhibiting a heat shock response and angiogenesis inhibition. Journal of medicinal chemistry 20080424
Investigating the antiproliferative activity of quinoline-5,8-diones and styrylquinolinecarboxylic acids on tumor cell lines. Bioorganic & medicinal chemistry letters 20071115
Synthesis and in vitro antitumor activity of ring C and D-substituted phenanthrolin-7-one derivatives, analogues of the marine pyridoacridine alkaloids ascididemin and meridine. Bioorganic & medicinal chemistry 20040801
Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity. Journal of medicinal chemistry 20040212
Synthesis and in vitro antitumor activity of novel ring D analogues of the marine pyridoacridine ascididemin: structure-activity relationship. Journal of medicinal chemistry 20020815
Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. Journal of medicinal chemistry 20011122
Synthesis of pyridino[2,3-f]indole-4,9-dione and 6,7-disubstituted quinoline-5,8-dione derivatives and evaluation on their cytotoxic activity. Bioorganic & medicinal chemistry 20011101
Comparative study on biological activities of heterocyclic quinones and streptonigrin. The Journal of antibiotics 19870501

Related Products

© 2019 Angene International Limited. All rights Reserved.